Cytokinetics, Incorporated (CYTK) Social Stream
CYTOKINETICS INC (CYTK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CYTOKINETICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $75 | $40 | $53.444 | $93.73 | -42.98% |
| 2021-12-01 | 9 | $75 | $40 | $53.5 | $93.73 | -42.92% |
| 2021-12-10 | 10 | $75 | $40 | $53.909 | $93.73 | -42.48% |
| 2021-12-21 | 10 | $75 | $40 | $54.545 | $93.73 | -41.81% |
| 2022-02-01 | 11 | $75 | $40 | $54.666 | $93.73 | -41.68% |
| 2022-02-15 | 11 | $75 | $40 | $54.5 | $93.73 | -41.85% |
| 2022-02-28 | 11 | $75 | $40 | $54.166 | $93.73 | -42.21% |
| 2022-03-02 | 11 | $75 | $40 | $53.916 | $93.73 | -42.48% |
| 2022-04-13 | 11 | $75 | $40 | $54.272 | $93.73 | -42.1% |
| 2022-04-29 | 11 | $75 | $40 | $55.181 | $93.73 | -41.13% |
| 2022-05-05 | 11 | $75 | $40 | $56.727 | $93.73 | -39.48% |
| 2022-05-16 | 11 | $80 | $40 | $59.909 | $93.73 | -36.08% |
| 2022-05-23 | 12 | $80 | $40 | $60.916 | $93.73 | -35.01% |
| 2022-05-26 | 12 | $80 | $40 | $59.5 | $93.73 | -36.52% |
| 2022-06-17 | 12 | $80 | $40 | $61.333 | $93.73 | -34.56% |
| 2022-08-05 | 10 | $80 | $54 | $64.545 | $93.73 | -31.14% |
| 2022-08-09 | 10 | $80 | $56 | $65.636 | $93.73 | -29.97% |
| 2022-08-12 | 10 | $80 | $15 | $61.545 | $93.73 | -34.34% |
| 2022-09-02 | 11 | $80 | $15 | $62.727 | $93.73 | -33.08% |
| 2022-10-03 | 11 | $82 | $15 | $64.333 | $93.73 | -31.36% |
| 2022-11-03 | 12 | $82 | $15 | $65.538 | $93.73 | -30.08% |
| 2022-11-20 | 12 | $82 | $57 | $69 | $93.73 | -26.38% |
| 2022-12-09 | 12 | $82 | $55 | $68.307 | $93.73 | -27.12% |
| 2022-12-14 | 12 | $82 | $55 | $67.923 | $93.73 | -27.53% |
| 2022-12-15 | 12 | $82 | $55 | $66.461 | $93.73 | -29.09% |
| 2022-12-20 | 14 | $82 | $55 | $65 | $93.73 | -30.65% |
| 2022-12-23 | 14 | $82 | $55 | $64.857 | $93.73 | -30.8% |
| 2023-02-14 | 14 | $80 | $47 | $62.357 | $93.73 | -33.47% |
| 2023-02-21 | 15 | $80 | $47 | $61.466 | $93.73 | -34.42% |
| 2023-03-01 | 15 | $80 | $47 | $61.4 | $93.73 | -34.49% |
| 2023-03-02 | 15 | $80 | $48 | $61.533 | $93.73 | -34.35% |
| 2023-03-06 | 15 | $80 | $48 | $61.933 | $93.73 | -33.92% |
| 2023-03-07 | 15 | $80 | $48 | $61.933 | $93.73 | -33.92% |
| 2023-03-20 | 15 | $80 | $48 | $61.733 | $93.73 | -34.14% |
| 2023-03-31 | 15 | $80 | $42 | $61.2 | $93.73 | -34.71% |
| 2023-04-03 | 15 | $80 | $42 | $60.533 | $93.73 | -35.42% |
| 2023-04-18 | 15 | $80 | $42 | $60.2 | $93.73 | -35.77% |
| 2023-05-05 | 15 | $80 | $41 | $60.133 | $93.73 | -35.84% |
| 2023-06-06 | 15 | $80 | $41 | $60.533 | $93.73 | -35.42% |
| 2023-08-07 | 16 | $80 | $41 | $60.666 | $93.73 | -35.28% |
| 2023-08-15 | 15 | $80 | $41 | $60.5 | $93.73 | -35.45% |
| 2023-10-09 | 14 | $80 | $41 | $61 | $93.73 | -34.92% |
| 2023-10-19 | 14 | $80 | $41 | $61.4 | $93.73 | -34.49% |
| 2023-10-20 | 14 | $80 | $41 | $62 | $93.73 | -33.85% |
| 2023-11-06 | 14 | $80 | $41 | $61.6 | $93.73 | -34.28% |
| 2023-11-07 | 15 | $80 | $41 | $61.875 | $93.73 | -33.99% |
| 2023-12-06 | 16 | $80 | $41 | $61.176 | $93.73 | -34.73% |
| 2023-12-22 | 15 | $80 | $41 | $61.062 | $93.73 | -34.85% |
| 2023-12-28 | 16 | $107 | $48 | $73.352 | $93.73 | -21.74% |
The Trend in the Analyst Price Target
Over the past 19 months, CYTK's average price target has gone up $13.85.
CYTK reports an average of 69.71% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-14 | 14 | 80 | 47 | 62.357 | 43.35 | 43.85% |
| 2023-02-21 | 15 | 80 | 47 | 61.466 | 42.04 | 46.21% |
| 2023-05-05 | 15 | 80 | 41 | 60.133 | 39.44 | 52.47% |
| 2023-12-06 | 15 | 80 | 41 | 61.062 | 33.46 | 82.49% |
| 2023-12-06 | 16 | 80 | 41 | 61.176 | 33.46 | 82.83% |
CYTK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 13 | 2 | 1 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 23 months, CYTK's average broker recommendation rating improved by 0.02.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CYTK as an investment opportunity.
- CYTOKINETICS INC's upside potential (average analyst target price relative to current price) is greater than 182.93% of all US stocks.
- In terms of how CYTOKINETICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 5056.17% of that group.
- CYTOKINETICS INC's average analyst price target is greater than 4440.97% of Pharmaceutical Products stocks.
- In the context of stocks in the mid market cap category, CYTOKINETICS INC's variance in analysts' estimates is lower than -3944.73% of them.
In the Pharmaceutical Products industry, TGTX, MNKD, and LGND are the three stocks most similar to CYTOKINETICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CYTK using the data that counts. Try POWR Ratings for free.